Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Subscribe To Our Newsletter & Stay Updated
